Northwestern Medicine initiates Phase I trial of stem cells + cold virus for glioma
US-based advanced healthcare solutions provider Northwestern Medicine has initiated the Phase I trial of a new neural stem-cell therapy in combination with a common cold virus to detect and destroy brain cancer in patients with malignant glioma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Common Cold | Glioma | Neurology | Pharmaceuticals | Stem Cell Therapy | Stem Cells